These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 3549159)

  • 21. Fungal morphogenesis and virulence.
    San-Blas G; Travassos LR; Fries BC; Goldman DL; Casadevall A; Carmona AK; Barros TF; Puccia R; Hostetter MK; Shanks SG; Copping VM; Knox Y; Gow NA
    Med Mycol; 2000; 38 Suppl 1():79-86. PubMed ID: 11204167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis.
    Goldman RC; Frost DJ; Capobianco JO; Kadam S; Rasmussen RR; Abad-Zapatero C
    Infect Agents Dis; 1995 Dec; 4(4):228-47. PubMed ID: 8665087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
    Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
    Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis].
    Toyotome T; Watanabe A; Kamei K
    Nihon Rinsho; 2008 Dec; 66(12):2255-60. PubMed ID: 19069088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
    Karkowska-Kuleta J; Rapala-Kozik M; Kozik A
    Acta Biochim Pol; 2009; 56(2):211-24. PubMed ID: 19543556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on antifungal resistance.
    Klepser ME; Ernst EJ; Pfaller MA
    Trends Microbiol; 1997 Sep; 5(9):372-5. PubMed ID: 9294895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    Morace G; Polonelli L;
    Int J Antimicrob Agents; 2005 Sep; 26(3):247-53. PubMed ID: 16051469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans.
    Whelan WL
    Crit Rev Microbiol; 1987; 15(1):45-56. PubMed ID: 3319420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual reproduction of human fungal pathogens.
    Heitman J; Carter DA; Dyer PS; Soll DR
    Cold Spring Harb Perspect Med; 2014 Aug; 4(8):. PubMed ID: 25085958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Friend or foe: using systems biology to elucidate interactions between fungi and their hosts.
    Rizzetto L; Cavalieri D
    Trends Microbiol; 2011 Oct; 19(10):509-15. PubMed ID: 21871806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.
    Zhang JD; Xu Z; Cao YB; Chen HS; Yan L; An MM; Gao PH; Wang Y; Jia XM; Jiang YY
    J Ethnopharmacol; 2006 Jan; 103(1):76-84. PubMed ID: 16169173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes.
    Ng CK; Singhal V; Widmer F; Wright LC; Sorrell TC; Jolliffe KA
    Bioorg Med Chem; 2007 May; 15(10):3422-9. PubMed ID: 17383187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual reproduction and the evolution of microbial pathogens.
    Heitman J
    Curr Biol; 2006 Sep; 16(17):R711-25. PubMed ID: 16950098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of pathogenic fungi: some recent developments and perspectives.
    Ernst JF
    Mycoses; 1990 May; 33(5):225-9. PubMed ID: 2266998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic fungi in the 21st century.
    Odds FC
    Trends Microbiol; 2000 May; 8(5):200-1. PubMed ID: 10785633
    [No Abstract]   [Full Text] [Related]  

  • 39. Biotyping of medically important fungi.
    Odds FC
    Curr Top Med Mycol; 1985; 1():155-71. PubMed ID: 3916765
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell wall proteome of pathogenic fungi.
    Karkowska-Kuleta J; Kozik A
    Acta Biochim Pol; 2015; 62(3):339-51. PubMed ID: 26192771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.